ZA925130B - Pharmaceutical formulation. - Google Patents

Pharmaceutical formulation.

Info

Publication number
ZA925130B
ZA925130B ZA925130A ZA925130A ZA925130B ZA 925130 B ZA925130 B ZA 925130B ZA 925130 A ZA925130 A ZA 925130A ZA 925130 A ZA925130 A ZA 925130A ZA 925130 B ZA925130 B ZA 925130B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
cetomacrogol
penciclovir
mucosa
skin
Prior art date
Application number
ZA925130A
Other languages
English (en)
Inventor
Alan John Goodall
Hazel-Ann Griffths
Joshua Oduro-Yeboah
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA925130B publication Critical patent/ZA925130B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
ZA925130A 1991-07-11 1992-07-09 Pharmaceutical formulation. ZA925130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114939A GB9114939D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ZA925130B true ZA925130B (en) 1993-05-05

Family

ID=10698164

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925130A ZA925130B (en) 1991-07-11 1992-07-09 Pharmaceutical formulation.

Country Status (19)

Country Link
EP (1) EP0593562B1 (ko)
JP (1) JP2865867B2 (ko)
KR (1) KR100245016B1 (ko)
AT (1) ATE177638T1 (ko)
AU (2) AU2230792A (ko)
CA (1) CA2113080C (ko)
DE (1) DE69228686T2 (ko)
DK (1) DK0593562T3 (ko)
ES (1) ES2128353T3 (ko)
GB (1) GB9114939D0 (ko)
GR (1) GR3029886T3 (ko)
HK (1) HK1012242A1 (ko)
IE (1) IE922263A1 (ko)
MX (1) MX9204030A (ko)
NZ (1) NZ243490A (ko)
PT (1) PT100670B (ko)
TW (1) TW328049B (ko)
WO (1) WO1993000905A1 (ko)
ZA (1) ZA925130B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
CN109481674A (zh) * 2018-11-14 2019-03-19 大连亚维药业有限公司 一种生物无菌乳膏药物的生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
DE69228686D1 (de) 1999-04-22
AU4040195A (en) 1996-02-22
ES2128353T3 (es) 1999-05-16
PT100670B (pt) 1999-07-30
GR3029886T3 (en) 1999-07-30
CA2113080A1 (en) 1993-01-21
TW328049B (en) 1998-03-11
EP0593562A1 (en) 1994-04-27
KR100245016B1 (ko) 2000-03-02
EP0593562B1 (en) 1999-03-17
DK0593562T3 (da) 1999-09-27
DE69228686T2 (de) 1999-09-09
AU698847B2 (en) 1998-11-12
IE922263A1 (en) 1993-01-13
GB9114939D0 (en) 1991-08-28
HK1012242A1 (en) 1999-07-30
AU2230792A (en) 1993-02-11
JPH06508845A (ja) 1994-10-06
ATE177638T1 (de) 1999-04-15
MX9204030A (es) 1993-02-01
CA2113080C (en) 2003-02-25
WO1993000905A1 (en) 1993-01-21
PT100670A (pt) 1993-10-29
NZ243490A (en) 1995-03-28
JP2865867B2 (ja) 1999-03-08

Similar Documents

Publication Publication Date Title
BR9713677B1 (pt) formulações em gel para liberação tópica de droga.
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
NO943837D0 (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater
GB9103764D0 (en) Compositions
GB9114939D0 (en) Pharmaceutical formulation
MY110074A (en) Pharmacuetical formulation.
ES2091941T3 (es) Potenciador del efecto antineoplasico y agente antineoplasico.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR910004186A (ko) 제약학적 배합물
AR007983A1 (es) Formulacion
SE8802257D0 (sv) Antimikrobiell komposition
IT1247695B (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
IT1254361B (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
ITRM920516A1 (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
IT1242000B (it) Impiego di sali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana.
UA39988C2 (uk) Антимікробний засіб" асперсепт" та спосіб лікування та профілактики інфекційних уражень шкіри за допомогою цього засобу